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The fundamental challenge of aging and long-term survivorship is maintenance of 
functional independence and compression of morbidity despite a life history of disease. 
Inasmuch as immunity is a determinant of individual health and fitness, unraveling novel 
mechanisms of immune homeostasis in late life is of paramount interest. Comparative 
studies of young and old persons have documented age-related atrophy of the thy-
mus, the contraction of diversity of the T cell receptor (TCR) repertoire, and the intrinsic 
inefficiency of classical TCR signaling in aged T cells. However, the elderly have highly 
heterogeneous health phenotypes. Studies of defined populations of persons aged 75 
and older have led to the recognition of successful aging, a distinct physiologic construct 
characterized by high physical and cognitive functioning without measurable disability. 
Significantly, successful agers have a unique T cell repertoire; namely, the dominance of 
highly oligoclonal αβT cells expressing a diverse array of receptors normally expressed 
by NK cells. Despite their properties of cell senescence, these unusual NK-like T cells 
are functionally active effectors that do not require engagement of their clonotypic TCR. 
Thus, NK-like T cells represent a beneficial remodeling of the immune repertoire with 
advancing age, consistent with the concept of immune plasticity. Significantly, certain 
subsets are predictors of physical/cognitive performance among older adults. Further 
understanding of the roles of these NK-like T cells to host defense, and how they inte-
grate with other physiologic domains of function are new frontiers for investigation in 
Aging Biology. Such pursuits will require a research paradigm shift from the usual young-
versus-old comparison to the analysis of defined elderly populations. These endeavors 
may also pave way to age-appropriate, group-targeted immune interventions for the 
growing elderly population.
Keywords: CD16, CD56, cell senescence, functional performance, immune remodeling, NKG2D, plasticity, 
TCR-independent
Abbreviations: 3MS, average of three tests of the modified minimental examination; ADL, activities of daily living; GMFI, 
geometric mean fluorescence intensity; IFN, interferon; IL, interleukin; TCR, T cell receptor; TNF, tumor necrosis factor.
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iNTRODUCTiON: ALTeRATiONS iN 
CLASSiCAL T CeLL-MeDiATeD 
iMMUNiTY DURiNG AGiNG
Studies comparing young and old humans and mice have led to 
a voluminous body of literature showing a general age-related 
decline in various physiologic functions. In the immune system, 
among the most notable age-dependent physiologic retrogres-
sions in the T cell compartment are inefficiencies in classical 
T cell receptor (TCR) signaling, thymic involution, contraction 
of the naïve T compartment, expansion of the memory T cell 
compartment, and overall shortening of telomeres (1–8). At the 
cellular level, aged CD4+ and CD8+ T cells have a deficiency in the 
expression of CD28 that coincides with highly shortened telom-
eres, high levels of expression of mitotic inhibitors, such as p16 
and p53, and a severe limitation or complete lack of mitotic activ-
ity (9–13). All of these alterations have been argued to underlie 
the relative poorer antigen-specific T cell-dependent immunity 
among older adults compared to younger persons.
HeTeROGeNeiTY OF PHeNOTYPeS OF 
OLDeR ADULTS
Older adults (generally defined as those aged ≥65 years), however, 
have highly heterogeneous health and immune phenotypes. They 
range from the frail and chronically ill residents of long-term care 
facilities to the community dwellers that are living independently 
(14–17). Many of them retain their ability to mount vaccine 
responses, including to the pandemic and seasonal influenza 
vaccines, and to the zoster vaccine (18–22). There are evidences 
of functionally active virus-specific T cells during new and reac-
tivated latent infections (23–25). Old age has also become less 
of hurdle in the setting of organ transplantation for either organ 
donors or recipients (26–29). Thus, aging is not synonymous with 
poor health, or that the elderly are not mere defective versions of 
the young.
Heterogeneity of older adults provides a compelling rationale 
for a re-appraisal of “immunosenescence.” In its current usage, 
the term refers to the poorer degree of immune responsiveness 
of older adults relative to that seen in the young, a generalized 
and vague definition that has not substantially differed from 
the original concept proposed by Walford in the 1950s (30). 
Learning from epidemiological and geriatric studies (14–17, 31), 
we have articulated the paramount importance for the analysis 
of defined populations of the elderly, instead of continuing with 
the usual young-versus-old comparative approach. Such research 
paradigm shift is a key toward unraveling immunopathways that 
underlie discrete physiologic constructs of aging, such as frailty 
and successful aging (32, 33).
iRReveRSiBLe LOSS OF CD28:  
A SiGNATURe OF AGiNG iN HUMAN  
T CeLLS
CD28 is the major co-stimulatory molecule that is required to 
sustain normal T cell activation (34) and for the elaboration of 
antigen-specific effector function in both naïve and memory 
compartments (35–37). In cohort studies, we provided the 
definitive proof for progressive loss of CD28 with chronologic 
aging (12). Such loss or absence of CD28 has long been thought to 
lead to deficiency or inefficiency of TCR signaling in aged T cells 
(10, 38). Indeed, mice with homozygous deletion of CD28 results 
in an immunosuppressed phenotype, since mouse CD28−/− T cells 
are anergic and prone to activation-induced cell death (35, 39).
The loss of CD28 on human T cells with aging (10, 12, 40) may 
not be surprising since CD28 expression is subject to transient 
downregulation during a normal immune response (41). In fact, 
deficiency of its expression is characteristic of continuous pas-
sages of T cell cultures (40, 42). These unusual CD28null CD8+ 
T cells have shortened telomeres (13), consistent with telomere-
dependent senescence (sometimes referred to as “replicative 
senescence”) akin to those reported for other human somatic 
cells (43–47).
Due to more rapid turnover, CD8+ T cells have higher rate 
of CD28 loss than CD4+ T cells (48, 49). CD28null CD4+ and 
CD8+ T cells are highly oligoclonal and have highly shortened 
telomeres, indicating their long replicative history (12, 13). They 
also have high expression levels of p16 and 53, and they have 
limited, if not complete lack of, proliferative capacity even under 
conditions of optimal stimulation via TCR/CD3 in the presence 
of interleukin (IL)-2 in vitro (11, 12, 50, 51). All these properties 
are consistent with replicative senescence.
CD28 loss and telomere shortening are properties of primates, 
being typical of elderly humans as described above, as well as 
for older macaques and other anthropoids (52–55). In contrast, 
mouse T cells maintain long telomeres, and neither CD4+ nor 
CD8+ T cells show perceptible telomere shortening with multiple 
cell divisions in vitro (56). Indeed, it takes at least four generations 
for the telomerase-deficient mouse to show quantitative shorten-
ing of telomeres (57), indicating mice clearly do not undergo 
telomere-dependent replicative senescence.
Clonal expansions of T cells are characteristic of old mice simi-
lar to old humans (58). However, mouse T cells do not lose CD28 
expression with chronologic aging. In fact, CD28 expression 
level may actually increase with age (59). Such species-specific 
difference in CD28 expression pattern between humans and 
mice is attributable to entirely non-homologous DNA sequences 
in the promoter regions of the CD28 gene (60) (Homo sapiens 
CD28, NCBI Gene 940, HGNC 1653; Mus musculus CD28, MGI 
88327, NCBI Gene 12487). These age-related loss/maintenance 
of telomeres and loss of CD28 underscore that transposition of 
data obtained from mouse studies to human biology is unsound. 
We have articulated that while aging mouse models are instruc-
tive about the general biology of aging, they do not substitute for 
analytical studies of human elderly subjects (61).
The loss of CD28 is generally irreversible, due to the direct 
inactivation of the gene promoter (42, 62). The transcriptional 
initiator, a DNA sequence module in the 5′ cis-acting CD28 regu-
latory region where the activator complex, including nucleolin 
and heterogeneous ribonucleoprotein-DOA, is unoccupied in 
senescent CD28null T cells (63). Nucleolin and heterogeneous 
ribonucleoprotein-DOA are found in senescent T cells, but they 
do not form a functional initiator complex. While mechanism(s) 
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underlying the failure of the assembly of this transcriptional 
complex remains to be investigated, it is clear that non-occupancy 
of the CD28 initiator results in a transcriptional block, leading to 
the absence of all splice forms of CD28 mRNA and the lack of 
expression of CD28 on the T cell surface (42, 64, 65).
CD28null T cells are resistant to apoptosis (66), which explains 
their persistence in circulation for years and their pervasive 
accumulation in  vivo with advancing age. This is attributed to 
constitutively high levels of expression of Bcl2 and Bcl-xL, with 
corresponding downregulation of Bax (12, 67). Bcl-independent 
pathways for the lifelong persistence of these cells have also been 
reported (68).
DE NOVO eXPReSSiON OF NK-ReLATeD 
ReCePTORS ON CD28null T CeLLS: 
FUNCTiONAL DiveRSiTY AND 
veRSATiLiTY OF AGeD T CeLLS
Whether they are naturally derived in vivo during aging, or in an 
in vitro senescence system, oligoclonal senescent CD28null T cells 
have a unique phenotype for their de novo acquisition of a diverse 
array of receptors normally expressed on NK cells (12, 50, 69, 70). 
The repertoire of NK-related receptors they express does not 
reflect the full complement of the many NK receptor genes 
normally expressed on NK cells (50). However, the NK-related 
receptors on aged CD28null T cells are expressed co-dominantly in 
varying combinations along clonal lineages. CD28null T cells with 
identical TCR CDR3 sequences, indicating their common origin 
from a single mother CD28+ T cell, may express different types of 
NK-related receptors (71, 72).
Whether the loss of CD28 is required for, or is an event inde-
pendent from, the expression of NK-related receptors remains to 
be examined. However, it is clear that differences in the patterns of 
expression of these receptors between NK cells and CD28null T cells 
are related to cell-specific differences in the regulatory modules 
of each NK-related receptor. For example, we have shown that 
differential expression of CD158b1 (KIR 2DL2) between T and 
NK cells are controlled by two distinct transcriptional regulatory 
motifs on the upstream cis-acting promoter region of the gene; 
namely, a proximal element at −51 and an AML site at position 
−98 for T and NK cells, respectively (73). Other investigators 
have reported the role of age-related epigenetic alterations. 
Differential induction of CD158d (KIR 2DL4) and CD158b2 
(KIR 2DL3) on T cells is related to methylation/demethylation on 
promoter regions of these two genes, in contrast to their classical 
promoter-driven expression as seen in NK cells (74–76). These 
studies suggest that there may be diverse regulatory machineries 
involved in the induction of NK-related receptors on T cells with 
aging. Given the diversity of these receptors and their apparent 
co-dominant expression, it will be of interest to examine whether 
and how expression of one NK-receptor affects the expression 
of another NK-receptor during the aging process. A particular 
interest is the regulation of expression of the prototypic recep-
tors CD56, CD16, and NKG2D on aged T cells. But regardless of 
whether such regulation occurs at the level of unique promoter 
motifs, or through structural alterations of chromatin that favor 
accessibility of the particular NK-receptor gene, or perhaps 
through posttranscription controls, it is clear that the acquisition 
of NK receptors by T cells corresponds with the elaboration of 
new effector function (77).
The phenomenal age-related expression of NK-related 
receptors on T cells has been associated with seropositivity 
to cytomegalovirus (CMV) (78). This is in line with reports 
about similar association of CMV serology with frequency 
of CD28null T cells, and such serological-cellular association 
has been argued to be a predictor of poor health outcomes of 
aging (79, 80). It has also been suggested that CMV infection 
may lead to the emergence of these senescent T cells that are 
considered dysfunctional or non-functional (81–83). However, 
such studies are purely associational rather than causal. Further, 
the association is not universal. The cited studies are mostly 
from those on elderly populations in Northern Europe where 
CMV exposure appears to occur gradually over the life span, 
which might explain the high CMV seropositivity in old age 
(80). In the United States, CMV exposure is already widespread 
at early adolescence (84). Yet, we have shown that senescent 
NK-like T cells are rarely found among young Americans 
(12, 32). Importantly, we found very high titers of anti-CMV 
antibody among older adults and found no clinical evidence of 
CMV disease. Indeed, another cohort study showed CMV sero-
positivity alone is an insufficient measure of health risk among 
older Americans (85). In addition, populations of CMV-specific 
T cells have been found to be functional with clear beneficial 
antiviral effects (68, 86, 87). A recent experimental study has 
shown further that CMV by itself does not induce replicative 
senescence for T cells (25). CMV disease is undoubtedly serious 
whether it happens at an early or old age. However, the causative 
role of CMV in human T cell senescence is yet to be proven. 
Broader experimental studies are needed to determine what 
particular environmental and/or endogenous factors trigger, 
drive, and maintain populations of senescent NK-like T cells 
in vivo during the aging process.
The array of NK-related receptors expressed on aged CD28null 
T cells is summarized in Figure 1. They include the prototypic 
stimulatory NK receptors, CD16, CD56, and NKG2D. They may 
also express CD161, and various inhibitory NK receptors such 
as CD94 and NKG2A, and members of the CD158 killer cell 
immunoglobulin-like receptor family (12, 50, 69, 72, 77, 88–90). 
Unlike the selective single allelic expression for TCR, NK-related 
receptors are expressed co-dominantly on aged T cells.
In addition to shortened telomeres, high p16/53 expression 
levels, and irreversible loss of CD28, aged NK-like T cells express 
two other markers of senescence, namely, KLRG1 and CD57 (81, 
91, 92). KLRG1 is an inhibitory NK-related receptor that has been 
shown to actively suppress classical TCR signaling (93). CD57 is 
an adhesion molecule that is typically expressed on terminally 
differentiated T cells. Although it is still unclear if CD57 itself is 
a signaling receptor that dictates or alters T cell effector function, 
its expression on T cells is biomarker for cell cycle arrest in aged 
T cells (91, 94). It might be noted that CD57 is also expressed on 
highly differentiated NK cells (95, 96). However, whether such 
CD57+ NK cells are senescent, and that CD57 directly controls 
NK cell function are also not yet known.
FiGURe 1 | Diagrammatic comparison between conventional CD28+ and senescent CD28null NK-like T cells. This illustration summarizes findings from 
various investigators as described in the text. The diagram shown was modified from (32) with permission from Aging and Disease journal under the terms of 
Creative Commons Attribution License (CC BY). This license allows the unrestricted use, distribution, modification, and reproduction in any medium by the author 
with credited citation of the original publication.
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Despite their senescent properties, CD28null NK-like T cells 
are highly functional and versatile. While there is general trend 
for the varying inefficiencies of classical TCR signaling during 
aging (1, 2, 97–99), there could still be residual TCR signaling as 
exemplified by long-lived memory T cells in the context small pox 
and polio vaccination (100, 101). Indeed, experimental studies 
showing unusually high constitutive level of expression of inter-
feron (IFN) γ in CD28null T cells can further increase following 
ligation of TCR/CD3 (38, 94, 102). Such residual TCR-driven 
response may be attributed to other co-stimulatory molecules, 
such as 41BB ligand, OX40, CD70, and CD58, which substitutes 
for the defunct CD28 (103–107).
More significantly, we have reported that effector activities of 
CD28null NK-like CD4+ and CD8+ T cells are directly attributable 
to signaling of the NK-related receptors they express in a totally 
TCR-independent manner (12, 70). We have shown that CD56-
driven and NKG2D-driven expression of the early activation 
cell surface antigen CD69; the intracellular expression of IL-4, 
IFNγ, CD107b/LAMP2, perforin, and granzyme; and the late 
cell surface expression of exocytosis protein CD107a are to be 
as effective as, if not better than, classical TCR stimulation. In 
fact, the CD56-/NKG2D-driven TCR-independent expression of 
perforin, granzyme, and CD107a occur in both CD4+ and CD8+ 
NK-like T cells. This indicates that the conventional “helper” 
and “cytotoxic” designations for CD4+ and CD8+ T cells, respec-
tively, are not instructive about of the biology of T cells in old 
age. Similarly, the expression of CD154 (CD40 ligand) on aged 
T cells does not follow the usual CD4 helper paradigm. CD154 
is lost on senescent CD28null CD4+ NK-like T cells but is gained 
by senescent CD28null CD8+ NK-like T cells (38, 108, 109). This 
suggests that the latter cell subset is a potential target to boost 
humoral immunity in the elderly.
AGe-DePeNDeNT ACCUMULATiON  
OF CD28null NK-LiKe T CeLLS wiTH 
OLiGOCLONAL TCRs: iMMUNe 
RePeRTOiRe ReMODeLiNG CONSiSTeNT 
wiTH PHYSiOLOGiC PLASTiCiTY  
iN OLD AGe
Physiologic systems are optimized toward reproduction, after 
which the goal is individual survival (110). There is evolutionary 
conservation of biological pathways that ensure individual sur-
vival beyond reproductive maturity (111, 112), including a variety 
of genes referred to as “longevity assurance” genes that promote 
long-term survival (113–116). Older organisms are essential in 
maintaining population structures particularly among social 
animals and are therefore involved ultimately in the perpetuation 
of the species (112, 117–119).
Immunity is an evolutionary determinant of individual fitness 
and survival (120–122). The accumulation of NK-like CD28null 
T  cells with advancing age represents a remodeling of the 
immune repertoire as a compensatory mechanism for the general 
age-related losses in conventional T cell-dependent immunity 
(123). As described previously, there is thymic atrophy with age 
leading to impaired production of new naïve T cells, making 
older adults unable to respond to new and emerging pathogens 
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in an antigen-specific manner (3, 124). With antigenic exposure 
through life, there is progressive contraction of the naïve T cell 
compartment, with corresponding expansion of memory and 
senescent T cell compartment. These events over the lifespan 
result in the contraction of diversity of the clonotypic TCR 
repertoire (5, 49). With cycles of expansion and death of T cells 
during antigenic challenges, the phenomenal accumulation of 
apoptosis-resistant CD28null NK-like T cells is likely a protection 
against clinical lymphopenia, which is very rare among older 
adults (125, 126).
The acquisition of a diverse array of NK-related receptors on 
CD28null T cells maintains immunologic diversity in old age. As 
discussed previously, there is co-dominant expression of diverse 
NK-related receptors along clonal lineages of CD28null T cells in 
late life. This is in stark contrast to the conventional clonotypic 
TCR diversity that is characteristic of the young. Signaling of 
these NK-related receptors effectively imparts an innate function 
to aged T cells (12, 70); hence, we had originally introduced the 
term “NK-like T cells” to emphasize their NK-related receptor-
driven, TCR-independent effector function (50). The term under-
lines the diverse array of NK-related receptors expressed along 
oligoclonal TCRαβ lineages, in contrast to convention αβTCR 
repertoire diversity in the young (12). NK-like T cells are distinct 
from conventional NKT cells (or invariant iNKT cells), which 
are identified a single invariant TCR AV24BV11 that recognizes 
glycolipid antigens presented in the context of CD1d instead of 
conventional HLA antigen-presenting molecules (127, 128).
NK-like T cells compensate for the corresponding age-related 
functional loses in the NK cell compartment (32). NK cell num-
bers are largely maintained through life, but skewing of certain NK 
cell subsets with aging have been reported (129). We have shown 
that octo-/nona-genarians have contracted pools of CD56+ and 
CD16+ NK cells, which are accompanied by corresponding age-
dependent gains of CD56 and CD16 expression on both CD4+ 
and CD8+ T cells (32, 70). As already described previously, CD56 
ligation alone can drive T cell effector activities. The function of 
CD16 on NK-like T cells remains to be examined.
Induction of NK-related receptors on T cells may not be 
surprising since T cells and NK cells originate from a common 
lymphoid progenitor. We have shown that NK cells have an 
abundance of untranslated, but re-arranged, TCRαβ mRNA with 
sequences identical to those seen in T cells (130). Thus, induc-
ibility of NK-related receptors in senescent CD28null NK-like 
T cells is consistent with functional plasticity of T cells (131–133). 
Although the intricacies of T cell plasticity are still being inves-
tigated, such plasticity re-directs the elaboration of effector 
activities to ensure a vigorous immunity. In old age, signaling of 
effector activities of NK-like T cells through NK-related receptors 
is an adaptation of the aging immune system. Such adaptation is 
a way to maintain immune homeostasis despite the inefficiency 
of classical TCR signaling and the contraction of diversity of the 
repertoire of clonotypic TCRs. NK-like T cells are highly resistant 
to cell death (12) and may represent Darwin’s “fittest” lympho-
cytes that contribute to immune function into old age.
Cell senescence is undoubtedly a characteristic of old organ-
isms, and it contributes to age-related malfunction in various 
tissues/organs (44, 134, 135). However, cell senescence also has 
physiologic benefits. Among these is its role in tumor suppres-
sion (134, 136, 137). Cell senescence also plays a role in tissue 
repair (138), such as in the prevention of fibrosis in liver, skin, 
kidney, and heart, and in the prevention of atherosclerosis 
and pulmonary hypertension (139). In addition, there is also 
programed cell senescence, which is an essential component of 
embryogenesis (140–142). Along these lines, the age-dependent 
emergence of functionally competent senescent NK-like CD28null 
T cells represents a significant and beneficial remodeling of the 
immune repertoire (123).
T cell repertoire remodeling through the de novo expression of 
NK-related receptors along clonal lineages of senescent CD28null 
T cells is also consistent with age-related functional plasticity in 
certain organ systems. For example, there is age-related structural 
and functional decline in the central nervous system that leads to 
varying degrees of cognitive impairment, such as dementia and 
Alzheimer’s disease. There is heritability of high cognitive func-
tion into old age (143, 144). The roles of specific genes or gene 
polymorphisms, and epigenetic programs have been reported 
(114, 115, 119, 145–150). But the apparent “default” trajectory 
of age-related cognitive decline may be altered by physical 
activity, inclusive of regimented exercise, strength training, or 
usual activity such as walking. This has been best illustrated by 
improvement of various aspects of cognitive function, including 
memory and learning, among older adults engaged in regular 
physical activity (151–158). Functional brain imaging show 
extraordinary brain networks of neurocognitive performance 
following physical activity (159–161). In experimental animals, 
physical activity elicits an array of genes, along with epigenetic 
changes, associated with improvement in neurobehavioral 
performance (162–165). While the mechanisms underlying the 
improvement of brain/cognitive function with physical activity 
need to be examined further, aging of the brain is undoubtedly 
amenable to modulation.
Similarly, aging leads to a decline skeletal muscle function, 
including an age-related inefficiency of muscle mitochondria. Yet, 
the aging skeletal muscle is functionally plastic. Whereas certain 
gene polymorphisms have been implicated to maintain muscle 
function with age (166), physical activity has been shown to 
improve muscle and mitochondrial function among older adults 
(167–170). An important component of physical activity-induced 
improvement of function of the aging muscle is the equally plas-
tic satellite cells that maintain muscle organization (171, 172). 
Clearly, certain physiologic systems including immune cells are 
functionally plastic, a property that may be exploited to maintain, 
if not improve, functional performance in old age.
NK-LiKe T CeLL SUBSeTS ARe 
BiOiNDiCATORS OF SUCCeSSFUL  
AGiNG AND LONGeviTY
As described previously, older adults are highly heterogeneous, 
with varying health phenotypes and life expectancy. An improved 
understanding of this heterogeneity has been facilitated by 
objective measurements of physical and cognitive function. Such 
measurements have led to better stratification of elders; from 
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frail residents of long-term care facilities, to successfully aging 
community dwellers (16, 31, 153, 173–177). Thus, we have been 
proponents for the integration of immunity with other domains 
of function (32).
Integration of immunity to other physiologic systems may 
be best illustrated by our cross sectional study of the All Stars 
cohort (70) of the survivors from the Cardiovascular Health 
Study, a multicenter long-term study of aging (16, 178, 179). 
Categorization of elders was based on cognition scores (3MS), 
measured by the average of three tests using the modified 
minimental examination (180), and self report of difficulty in 
performing activities of daily living (ADL), namely, dressing, 
toileting, transferring, eating, and bathing (181). High func-
tioning (or “unimpaired”) was defined as 3MS score >80 and 
ADL =  0. The data showed that the stimulatory NK-related 
receptors CD16, CD56, and NKG2D in all T cell subsets were 
the most prominent cellular components of the immune 
signature of the high functioning group as determined by fac-
tor analysis. In contrast, the inhibitory NK-related receptors 
NKG2A, CD158a, and CD158e comprised the cell signature of 
the functionally impaired. In line with these fingerprints, logis-
tic regression analysis of the same dataset showed CD56 and 
CD16 expression was significant predictors of high functional 
performance. In contrast, NKG2A and CD158a were negative 
predictors. More importantly, CD28null T cells in the CD4 but 
not in the CD8, compartment expressing these four NK-related 
receptors were the cell subset predictor of high cognitive/physi-
cal functioning.
Another way to illustrate the relationship between NK-like 
CD28null T cells and physical/cognitive functioning is shown 
in Figure 2 with a three dimensional plot for CD16 or CD56 
expression levels (measured as GMFI, geometric mean fluores-
cence intensity), 3MS cognition score, and gait speed. The latter 
measure of physical function was determined by a 4-m walk 
test that has been standardized/validated from various cohort 
studies (16, 176). The data show a clear segregation between 
the high functioning and functionally impaired elders. This is 
surprising given that “impaired” and “unimpaired” categories in 
this graphical illustration are very loosely defined by ADL ≥ 1 
and ADL =  0, respectively. Therefore, it will be of significant 
interest to determine if this three-way relationship between 
subsets of NK-like T cells, physical function, and cognitive 
ability translates into vigorous immune defense. In addition, 
the underlying mechanistic link(s) between these three physi-
ologic systems will be instructive about integrative physiology 
of successful aging.
NK-LiKe T CeLLS iN YOUNG PeRSONS 
wiTH CHRONiC DiSeASeS: A CASe FOR 
ANTAGONiSTiC PLeiOTROPY
NK-like CD28null T cells represent a beneficial remodeling of the 
T cell repertoire with aging. Paradoxically, similar cells have also 
been found among young patients with chronic immune-medi-
ated diseases in an age-disproportionate manner. We have shown 
the infiltration of CD56+ CD28null CD4+ T cells in extra-articular 
lesions in rheumatoid arthritis (182). Inflammatory CD56+ 
T cells have been reported in coronary artery disease, asthma, 
ulcerative colitis, and chronic hepatitis C disease (183–186). 
NKG2D+ CD28null T cells have some tumor-promoting activ-
ity in experimental settings (187, 188) and as inflammatory 
mediators in Wegener’s granulomatosis, rheumatoid arthritis, 
juvenile-onset systemic lupus erythematosus, and celiac disease 
(189–192).
Many of these diseases have characteristic systemic upregula-
tion of TNFα (193). We have shown that TNFα can directly block 
the CD28 transcriptional initiator (65, 194). In a TNFα-rich 
environment, such as in the case of rheumatoid arthritis, we 
found that anti-TNF therapy prevents the TNFα-induced loss of 
CD28 on the residual CD28+ CD8+ and CD4+ T cells, but the 
numbers of CD28null T cells remain the same (194). Whether or 
not TNFα induces the gain NK-related receptors has not yet been 
examined.
Interestingly, CD56+/NKG2D+ T cells also have beneficial 
effects in disease settings. Regulatory CD56+ CD28null CD8+ 
T cells and NKG2D+ T cells have been reported in rheumatoid 
arthritis and in juvenile-onset systemic lupus erythematosus, 
respectively (195, 196). Similar NK-like T cell subsets appear to 
be normal components of regional host defense in the gut. They 
may have auxiliary antitumor effect and have been associated 
with antiviral immunity in the setting of allergies and chronic 
hepatitis B disease (197–200).
Such age-disproportionate emergence of senescent CD28null 
NK-like T cells supports the provocative idea that premature 
senescence of T cells is a critical factor in the pathogenesis and 
clinical prognosis of chronic diseases of the young (201). These 
apparent beneficial and detrimental effects of certain NK-like 
T  cell subsets among young patients, and the beneficial effects 
of similar cells during aging as described above, are consistent 
with the evolutionary concept of antagonistic pleiotropy (202). 
This concept posits that genes and biological pathways that are 
beneficial in the young may be detrimental in the old, and vice-
versa. Therefore, a scientific challenge is to determine conditions 
in disease states of the young where CD28null NK-like T cells 
might exert a pathogenic effect. It will be of similar interest to 
determine what drives the accumulation of beneficial senescent 
CD28null NK-like T cells during the aging process.
CONCLUSiON: THe CHALLeNGe OF 
HARNeSSiNG BeNeFiTS OF CD28null  
NK-LiKe T CeLLS
The expression of NK-related receptors along clonal lineages 
of CD28null T cells with aging clearly represents a reshaping or 
remodeling of the immune repertoire. T cell signaling through 
these receptors independent of the TCR also illustrates the 
emerging theme that cell senescence may not necessarily be 
synonymous with dysfunction. One scientific challenge is to 
determine what drives the induction of diversity of expression 
of NK-related receptors on T cells with advancing age. Another 
is to determine whether the TCR-independent effector func-
tion of NK-like T cells translates into vigorous immune defense 
FiGURe 2 | NK-like T cells are linked to high cognitive and physical function. Data shown are 3D scatter plot summaries from the re-analyses of our data 
from the All Stars cohort of the Cardiovascular Health Study (70). CD16 and CD56 expression on CD4+ CD28null and CD8+ CD28null T cells are expressed as GMFI, 
which was determined by multicolor flow cytometry. Older adults were grouped as unimpaired (solid triangles) or impaired (open circles) based on a simple criterion 
of ADL = 0 and ADL > 1, respectively. Measurements of 3MS cognition score and gait speed and ADL scoring are as described in the text.
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and/or immune surveillance in late life. A  corollary interest 
is a possible dual functionality of these T cells, namely, their 
ability to trigger a classic TCR-driven response, while triggering 
a complementary innate TCR-independent response mediated 
through the particular NK-receptor(s) they express. Plausibility 
of this dual function has been shown experimentally for the 
interaction between tumor cells and particular NK-like CD8+ 
T cell lines in  vitro (203). An equal challenge is to elucidate 
the paradoxical age-disproportionate accumulation of NK-like 
T cells in disease states. Whether they represent cells involved 
in tissue repair or if they are true pathogenic effectors will be 
instructive into harnessing or dampening their effector func-
tion in disease settings. During the aging process, the most 
significant challenge is to determine how and why particular 
subsets of NK-like CD28null T cells are closely linked to physical 
performance and cognitive ability. Dissecting these mecha-
nisms will depend on the analyses of defined populations of the 
elderly, rather than continuing with the usual young-versus-old 
comparisons.
AUTHOR CONTRiBUTiONS
JM, PG, and AV drafted and edited the manuscript. JM and PG 
generated the figures. AV secured funding.
ACKNOwLeDGMeNTS
The authors thank Dr. Roger S. Crowther for editing this 
manuscript.
FUNDiNG
Research is supported by grants from the American Federation 
for Aging Research (AFAR) and Ellison Medical Foundation 
(M12589), and the National Institutes of Health (R01 AG030734). 
Supplemental support is provided by the Pittsburgh Claude 
Pepper Older Americans Independence Center, an NIH-funded 
center of excellence (P30 AG024827). AV is recipient of the AFAR 
Julie Martin Career Award on Aging.
8Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
ReFeReNCeS
1. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ, Fulop T. Impact of age on 
T cell signaling: a general defect or specific alterations? Ageing Res Rev (2011) 
10(3):370–8. doi:10.1016/j.arr.2010.09.008 
2. Fulop T, Le Page A, Fortin C, Witkowski JM, Dupuis G, Larbi A. Cellular 
signaling in the aging immune system. Curr Opin Immunol (2014) 29:105–11. 
doi:10.1016/j.coi.2014.05.007 
3. Schulz AR, Malzer JN, Domingo C, Jurchott K, Grutzkau A, Babel N, et al. 
Low thymic activity and dendritic cell numbers are associated with the 
immune response to primary viral infection in elderly humans. J Immunol 
(2015) 195(10):4699–711. doi:10.4049/jimmunol.1500598 
4. Ventevogel MS, Sempowski GD. Thymic rejuvenation and aging. Curr Opin 
Immunol (2013) 25(4):516–22. doi:10.1016/j.coi.2013.06.002 
5. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, et al. The influence of age 
on T cell generation and TCR diversity. J Immunol (2005) 174(11):7446–52. 
doi:10.4049/jimmunol.174.11.7446 
6. Sfikakis PP, Gourgoulis GM, Moulopoulos LA, Kouvatseas G, 
Theofilopoulos AN, Dimopoulos MA. Age-related thymic activity in adults 
following chemotherapy-induced lymphopenia. Eur J Clin Invest. (2005) 
35(6):380–7. doi:10.1111/j.1365-2362.2005.01499.x 
7. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, 
et al. Shortage of circulating naive CD8(+) T cells provides new insights on 
immunodeficiency in aging. Blood (2000) 95(9):2860–8. 
8. Weng NP, Levine BL, June CH, Hodes RJ. Human naive and memory T lym-
phocytes differ in telomeric length and replicative potential. Proc Natl Acad 
Sci U S A (1995) 92(24):11091–4. doi:10.1073/pnas.92.24.11091 
9. Effros RB. Loss of CD28 expression on T lymphocytes: a marker of repli-
cative senescence. Dev Comp Immunol (1997) 21(6):471–8. doi:10.1016/
S0145-305X(97)00027-X 
10. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells 
in normal elderly humans: the T cell equivalent to “benign mono-
clonal gammapathy”. J Exp Med (1994) 179(2):609–18. doi:10.1084/
jem.179.2.609 
11. Scheuring UJ, Sabzevari H, Theofilopoulos AN. Proliferative arrest and cell 
cycle regulation in CD8(+)CD28(-) versus CD8(+)CD28(+) T cells. Hum 
Immunol (2002) 63(11):1000–9. doi:10.1016/S0198-8859(02)00683-3 
12. Lemster BH, Michel JJ, Montag DT, Paat JJ, Studenski SA, Newman AB, et al. 
Induction of CD56 and TCR-independent activation of T cells with aging. 
J Immunol (2008) 180(3):1979–90. doi:10.4049/jimmunol.180.3.1979 
13. Batliwalla FM, Rufer N, Lansdorp PM, Gregersen PK. Oligoclonal expansions 
in the CD8(+)CD28(-) T cells largely explain the shorter telomeres detected 
in this subset: analysis by flow FISH. Hum Immunol (2000) 61(10):951–8. 
doi:10.1016/S0198-8859(00)00157-9 
14. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. 
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 
(2001) 56(3):M146–56. doi:10.1093/gerona/56.3.M146 
15. Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, 
et al. Phenotype of frailty: characterization in the women’s health and aging 
studies. J Gerontol A Biol Sci Med Sci (2006) 61(3):262–6. doi:10.1093/
gerona/61.3.262 
16. Newman AB, Arnold AM, Sachs MC, Ives DG, Cushman M, 
Strotmeyer ES, et al. Long-term function in an older cohort – the cardio-
vascular health study all stars study. J Am Geriatr Soc (2009) 57(3):432–40. 
doi:10.1111/j.1532-5415.2008.02152.x 
17. Strotmeyer ES, Arnold AM, Boudreau RM, Ives DG, Cushman M, Robbins 
JA, et al. Long-term retention of older adults in the Cardiovascular Health 
Study: implications for studies of the oldest old. J Am Geriatr Soc (2010) 
58(4):696–701. doi:10.1111/j.1532-5415.2010.02770.x 
18. Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, Farrell DJ, et al. Older 
age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 
(2009) 361(20):2000–1. doi:10.1056/NEJMc0907256 
19. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. 
T cell responses are better correlates of vaccine protection in the elderly. 
J Immunol (2006) 176(10):6333–9. doi:10.4049/jimmunol.176.10.6333 
20. Shahid Z, Kleppinger A, Gentleman B, Falsey AR, McElhaney JE. Clinical 
and immunologic predictors of influenza illness among vaccinated older 
adults. Vaccine (2010) 28(38):6145–51. doi:10.1016/j.vaccine.2010.07.036 
21. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, 
et al. Varicella-zoster virus-specific immune responses in elderly recipients 
of a herpes zoster vaccine. J Infect Dis. (2008) 197(6):825–35. doi:10.1086/ 
528696 
22. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, 
et  al. Varicella-zoster virus-specific immune responses to herpes zoster in 
elderly participants in a trial of a clinically effective zoster vaccine. J Infect 
Dis. (2009) 200(7):1068–77. doi:10.1086/605611 
23. Zhou X, McElhaney JE. Age-related changes in memory and effector T cells 
responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. 
Vaccine (2011) 29(11):2169–77. doi:10.1016/j.vaccine.2010.12.029 
24. Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JG. Human 
CD28-CD8+ T cells contain greatly expanded functional virus-specific 
memory CTL clones. J Immunol (1999) 162(12):7569–77. 
25. Riddell NE, Griffiths SJ, Rivino L, King DC, Teo GH, Henson SM, et  al. 
Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not 
restricted by telomere-related senescence in young or old adults. Immunology 
(2015) 144(4):549–60. doi:10.1111/imm.12409 
26. Karatzas T, Bokos J, Katsargyris A, Diles K, Sotirchos G, Barlas A, et  al. 
Advanced donor age alone is not a risk factor for graft survival in kidney 
transplantation. Transplant Proc. (2011) 43(5):1537–43. doi:10.1016/ 
j.transproceed.2011.03.014 
27. Taner CB, Ung RL, Rosser BG, Aranda-Michel J. Age is not a contraindica-
tion for orthotopic liver transplantation: a single institution experience with 
recipients older than 75 years. Hepatol Int (2011) 6(1):403–7. doi:10.1007/
s12072-011-9286-7 
28. Alamo JM, Olivares C, Jimenez G, Bernal C, Marin LM, Tinoco J, et al. Donor 
characteristics that are associated with survival in liver transplant recipients 
older than 70 years with grafts. Transplant Proc (2013) 45(10):3633–6. 
doi:10.1016/j.transproceed.2013.10.031 
29. Paterno F, Wima K, Hoehn RS, Cuffy MC, Diwan TS, Woodle SE, et  al. 
Use of elderly allografts in liver transplantation. Transplantation (2016) 
100(1):153–8. doi:10.1097/TP.0000000000000806 
30. Walford RL. The immunologic theory of aging. Gerontologist (1964) 4:195–7. 
doi:10.1093/geront/4.4.195 
31. Christensen K, McGue M, Petersen I, Jeune B, Vaupel JW. Exceptional 
longevity does not result in excessive levels of disability. Proc Natl Acad Sci 
U S A (2008) 105(36):13274–9. doi:10.1073/pnas.0804931105 
32. Griffin P, Michel JJ, Huysman K, Logar AJ, Vallejo AN. Integration of immu-
nity with physical and cognitive function in definitions of successful aging. 
Aging Dis (2012) 3(1):34–50. 
33. Lowry KA, Vallejo AN, Studenski SA. Successful aging as a continuum of 
functional independence: lessons from physical disability models of aging. 
Aging Dis. (2012) 3(1):5–15. 
34. Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 costim-
ulation: from mechanism to therapy. Immunity (2016) 44(5):973–88. 
doi:10.1016/j.immuni.2016.04.020 
35. Noel PJ, Boise LH, Green JM, Thompson CB. CD28 costimulation prevents 
cell death during primary T cell activation. J Immunol (1996) 157(2):636–42. 
36. Boesteanu AC, Katsikis PD. Memory T cells need CD28 costimula-
tion to remember. Semin Immunol (2009) 21(2):69–77. doi:10.1016/ 
j.smim.2009.02.005 
37. Welten SP, Melief CJ, Arens R. The distinct role of T cell costimulation 
in antiviral immunity. Curr Opin Virol (2013) 3(4):475–82. doi:10.1016/ 
j.coviro.2013.06.012 
38. Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ. Functional 
properties of CD4+ CD28- T cells in the aging immune system. Mech Ageing 
Dev (1998) 102(2–3):131–47. doi:10.1016/S0047-6374(97)00161-9 
39. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, et al. 
Differential T cell costimulatory requirements in CD28-deficient mice. 
Science (1993) 261(5121):609–12. doi:10.1126/science.7688139 
40. Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, et  al. 
Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a 
possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 
(1994) 29(6):601–9. doi:10.1016/0531-5565(94)90073-6 
41. Eck SC, Chang D, Wells AD, Turka LA. Differential down-regulation of 
CD28 by B7-1 and B7-2 engagement. Transplantation (1997) 64(10):1497–9. 
doi:10.1097/00007890-199711270-00025 
9Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
42. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ. Modulation of CD28 
expression: distinct regulatory pathways during activation and replicative 
senescence. J Immunol (1999) 162(11):6572–9. 
43. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. 
J Clin Invest (2004) 113(2):160–8. doi:10.1172/JCI20761 
44. Minamino T, Miyauchi H, Yoshida T, Tateno K, Kunieda T, Komuro I. 
Vascular cell senescence and vascular aging. J Mol Cell Cardiol (2004) 
36(2):175–83. doi:10.1016/j.yjmcc.2003.11.010 
45. Wege H, Chui MS, Le HT, Strom SC, Zern MA. In vitro expansion of human 
hepatocytes is restricted by telomere-dependent replicative aging. Cell 
Transplant (2003) 12(8):897–906. doi:10.3727/000000003771000138 
46. Ramirez RD, Herbert BS, Vaughan MB, Zou Y, Gandia K, Morales CP, 
et  al. Bypass of telomere-dependent replicative senescence (M1) upon 
overexpression of Cdk4 in normal human epithelial cells. Oncogene (2003) 
22(3):433–44. doi:10.1038/sj.onc.1206046 
47. Voghel G, Thorin-Trescases N, Farhat N, Nguyen A, Villeneuve L, 
Mamarbachi AM, et  al. Cellular senescence in endothelial cells from 
atherosclerotic patients is accelerated by oxidative stress associated with 
cardiovascular risk factors. Mech Ageing Dev (2007) 128(11–12):662–71. 
doi:10.1016/j.mad.2007.09.006 
48. Naumov YN, Naumova EN, Yassai MB, Gorski J. Selective T cell expansion 
during aging of CD8 memory repertoires to influenza revealed by modeling. 
J Immunol (2011) 186(11):6617–24. doi:10.4049/jimmunol.1100091 
49. Wack A, Cossarizza A, Heltai S, Barbieri D, D’Addato S, Fransceschi C, et al. 
Age-related modifications of the human alphabeta T cell repertoire due to 
different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 
(1998) 10(9):1281–8. doi:10.1093/intimm/10.9.1281 
50. Abedin S, Michel JJ, Lemster B, Vallejo AN. Diversity of NKR expression in 
aging T cells and in T cells of the aged: the new frontier into the exploration 
of protective immunity in the elderly. Exp Gerontol (2005) 40(7):537–48. 
doi:10.1016/j.exger.2005.04.012 
51. Perillo NL, Naeim F, Walford RL, Effros RB. The in vitro senescence of human 
T lymphocytes: failure to divide is not associated with a loss of cytolytic activ-
ity or memory T cell phenotype. Mech Ageing Dev (1993) 67(1–2):173–85. 
doi:10.1016/0047-6374(93)90121-7 
52. Jankovic V, Messaoudi I, Nikolich-Zugich J. Phenotypic and functional T-cell 
aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 
and CD8 subsets. Blood (2003) 102(9):3244–51. doi:10.1182/blood-2003-03- 
0927 
53. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, et  al. 
Development and homeostasis of T cell memory in rhesus macaque. 
J Immunol (2002) 168(1):29–43. doi:10.4049/jimmunol.168.1.29 
54. Steinert S, White DM, Zou Y, Shay JW, Wright WE. Telomere biology and 
cellular aging in nonhuman primate cells. Exp Cell Res (2002) 272(2):146–52. 
doi:10.1006/excr.2001.5409 
55. Trochet D, Mergui X, Ivkovic I, Porreca RM, Gerbault-Seureau M, Sidibe A, 
et al. Telomere regulation during ageing and tumorigenesis of the grey mouse 
lemur. Biochimie (2015) 113:100–10. doi:10.1016/j.biochi.2015.04.002 
56. Kipling D, Cooke HJ. Hypervariable ultra-long telomeres in mice. Nature 
(1990) 347(6291):400–2. doi:10.1038/347400a0 
57. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, et al. 
Telomere shortening and tumor formation by mouse cells lacking telomerase 
RNA. Cell (1997) 91(1):25–34. doi:10.1016/S0092-8674(01)80006-4 
58. Callahan JE, Kappler JW, Marrack P. Unexpected expansions of CD8-bearing 
cells in old mice. J Immunol (1993) 151(12):6657–69. 
59. Ortiz-Suarez A, Miller RA. A subset of CD8 memory T cells from old mice 
have high levels of CD28 and produce IFN-gamma. Clin Immunol (2002) 
104(3):282–92. doi:10.1006/clim.2002.5221 
60. Vallejo AN. CD28 extinction in human T cells: altered functions and 
the program of T-cell senescence. Immunol Rev (2005) 205:158–69. 
doi:10.1111/j.0105-2896.2005.00256.x 
61. Vallejo AN. Immunological hurdles of ageing: indispensable research 
of the human model. Ageing Res Rev (2011) 10(3):315–8. doi:10.1016/ 
j.arr.2011.01.005 
62. Vallejo AN, Nestel AR, Schirmer M, Weyand CM, Goronzy JJ. Aging-
related deficiency of CD28 expression in CD4+ T cells is associated with 
the loss of gene-specific nuclear factor binding activity. J Biol Chem (1998) 
273(14):8119–29. doi:10.1074/jbc.273.14.8119 
63. Vallejo AN, Bryl E, Klarskov K, Naylor S, Weyand CM, Goronzy JJ. Molecular 
basis for the loss of CD28 expression in senescent T cells. J Biol Chem (2002) 
277(49):46940–9. doi:10.1074/jbc.M207352200 
64. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 
expression by TNF-alpha. J Immunol (2001) 167(6):3231–8. doi:10.4049/
jimmunol.167.6.3231 
65. Lewis DE, Merched-Sauvage M, Goronzy JJ, Weyand CM, Vallejo AN. Tumor 
necrosis factor-alpha and CD80 modulate CD28 expression through a similar 
mechanism of T-cell receptor-independent inhibition of transcription. J Biol 
Chem (2004) 279(28):29130–8. doi:10.1074/jbc.M402194200 
66. Spaulding C, Guo W, Effros RB. Resistance to apoptosis in human CD8+ 
T cells that reach replicative senescence after multiple rounds of anti-
gen-specific proliferation. Exp Gerontol (1999) 34(5):633–44. doi:10.1016/
S0531-5565(99)00033-9 
67. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ. Clonality and longevity 
of CD4+CD28null T cells are associated with defects in apoptotic pathways. 
J Immunol (2000) 165(11):6301–7. doi:10.4049/jimmunol.165.11.6301 
68. Wallace DL, Masters JE, De Lara CM, Henson SM, Worth A, Zhang Y, et al. 
Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-
lived cells that retain functional capacity in both young and elderly subjects. 
Immunology (2011) 132(1):27–38. doi:10.1111/j.1365-2567.2010.03334.x 
69. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pena J, et al. Increased 
expression of NK cell markers on T lymphocytes in aging and chronic 
activation of the immune system reflects the accumulation of effector/
senescent T cells. Mech Ageing Dev (2000) 121(1–3):77–88. doi:10.1016/
S0047-6374(00)00199-8 
70. Vallejo AN, Hamel DL Jr, Mueller RG, Ives DG, Michel JJ, Boudreau RM, 
et al. NK-like T cells and plasma cytokines, but not anti-viral serology, define 
immune fingerprints of resilience and mild disability in exceptional aging. 
PLoS One (2011) 6(10):e26558. doi:10.1371/journal.pone.0026558
71. Snyder MR, Muegge LO, Offord C, O’Fallon WM, Bajzer Z, Weyand CM, 
et al. Formation of the killer Ig-like receptor repertoire on CD4+CD28null 
T cells. J Immunol (2002) 168(8):3839–46. doi:10.4049/jimmunol.168.8. 
3839 
72. Uhrberg M, Valiante NM, Young NT, Lanier LL, Phillips JH, Parham P. 
The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in 
T cells: clones sharing identical alpha beta TCR rearrangement express highly 
diverse killer cell Ig-like receptor patterns. J Immunol (2001) 166(6):3923–32. 
doi:10.4049/jimmunol.166.6.3923 
73. Xu J, Vallejo AN, Jiang Y, Weyand CM, Goronzy JJ. Distinct transcriptional 
control mechanisms of killer immunoglobulin-like receptors in natural killer 
(NK) and in T cells. J Biol Chem (2005) 280(25):24277–85. doi:10.1074/jbc.
M500727200 
74. Li G, Weyand CM, Goronzy JJ. Epigenetic mechanisms of  age-dependent 
KIR2DL4 expression in T cells. J Leukoc Biol (2008) 84(3):824–34. 
doi:10.1189/jlb.0807583 
75. Li G, Yu M, Weyand CM, Goronzy JJ. Epigenetic regulation of killer immu-
noglobulin-like receptor expression in T cells. Blood (2009) 114(16):3422–30. 
doi:10.1182/blood-2009-01-200170 
76. Strickland FM, Patel D, Khanna D, Somers E, Robida AM, Pihalja M, et al. 
Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell 
subset in autoimmune rheumatic diseases by multiparameter flow cytometry. 
Lupus Sci Med (2016) 3(1):e000147. doi:10.1136/lupus-2016-000147 
77. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P. Differential 
expression of leukocyte receptor complex-encoded Ig-like receptors cor-
relates with the transition from effector to memory CTL. J Immunol (2001) 
166(6):3933–41. doi:10.4049/jimmunol.166.6.3933 
78. Almehmadi M, Flanagan BF, Khan N, Alomar S, Christmas SE. Increased 
numbers and functional activity of CD56(+) T cells in healthy cytomega-
lovirus positive subjects. Immunology (2014) 142(2):258–68. doi:10.1111/
imm.12250 
79. Hooper M, Kallas EG, Coffin D, Campbell D, Evans TG, Looney  RJ. 
Cytomegalovirus seropositivity is associated with the expansion of 
CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol 
(1999) 26(7):1452–7. 
80. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Lofgren S, et al. 
An immune risk phenotype, cognitive impairment, and survival in very late 
life: impact of allostatic load in Swedish octogenarian and nonagenarian 
10
Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
humans. J Gerontol A Biol Sci Med Sci (2005) 60(5):556–65. doi:10.1093/
gerona/60.5.556 
81. Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, et al. 
Age-associated accumulation of CMV-specific CD8+ T cells expressing the 
inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol (2003) 
38(8):911–20. doi:10.1016/S0531-5565(03)00134-7 
82. Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, et al. Large 
numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single 
dominant CMV epitope in the very old. J Clin Immunol (2003) 23(4):247–57. 
doi:10.1023/A:1024580531705 
83. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. 
Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp 
Gerontol (2004) 39(4):607–13. doi:10.1016/j.exger.2003.11.016 
84. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the 
United States: the national health and nutrition examination surveys, 1988-
2004. Clin Infect Dis (2010) 50(11):1439–47. doi:10.1086/652438 
85. Leng SX, Li H, Xue QL, Tian J, Yang X, Ferrucci L, et al. Association of detect-
able cytomegalovirus (CMV) DNA in monocytes rather than positive CMV 
IgG serology with elevated neopterin levels in community-dwelling older 
adults. Exp Gerontol (2011) 46(8):679–84. doi:10.1016/j.exger.2011.04.002 
86. Lachmann R, Bajwa M, Vita S, Smith H, Cheek E, Akbar A, et al. Polyfunctional 
T cells accumulate in large human cytomegalovirus-specific T cell responses. 
J Virol (2012) 86(2):1001–9. doi:10.1128/JVI.00873-11 
87. Gehrz RC, Rutzick SR. Cytomegalovirus (CMV)-specific lysis of CMV-
infected target cells can be mediated by both NK-like and virus-specific 
cytotoxic T lymphocytes. Clin Exp Immunol (1985) 61(1):80–9. 
88. van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, 
Koning F. Phenotypic and functional characterization of CD4 T cells express-
ing killer Ig-like receptors. J Immunol (2004) 173(11):6719–26. doi:10.4049/
jimmunol.173.11.6719 
89. Fann M, Chiu WK, Wood WH III, Levine BL, Becker KG, Weng NP. Gene 
expression characteristics of CD28null memory phenotype CD8+ T cells 
and its implication in T-cell aging. Immunol Rev (2005) 205:190–206. 
doi:10.1111/j.0105-2896.2005.00262.x 
90. Peralbo E, Alonso C, Solana R. Invariant NKT and NKT-like lymphocytes: 
two different T cell subsets that are differentially affected by ageing. Exp 
Gerontol (2007) 42(8):703–8. doi:10.1016/j.exger.2007.05.002 
91. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, 
et al. Expression of CD57 defines replicative senescence and antigen-induced 
apoptotic death of CD8+ T cells. Blood (2003) 101(7):2711–20. doi:10.1182/
blood-2002-07-2103 
92. Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, et al. Impact 
of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and 
aging. PLoS One (2014) 9(2):e89444. doi:10.1371/journal.pone.0089444 
93. Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, Kiani-Alikhan S, 
et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and 
proliferative dysfunction of highly differentiated CD8+ T cells. Blood (2009) 
113(26):6619–28. doi:10.1182/blood-2009-01-199588 
94. Bandres E, Merino J, Vazquez B, Inoges S, Moreno C, Subira ML, et  al. 
The increase of IFN-gamma production through aging correlates with the 
expanded CD8(+high)CD28(-)CD57(+) subpopulation. Clin Immunol 
(2000) 96(3):230–5. doi:10.1006/clim.2000.4894 
95. Campos C, Pera A, Sanchez-Correa B, Alonso C, Lopez-Fernandez I, 
Morgado S, et  al. Effect of age and CMV on NK cell subpopulations. Exp 
Gerontol (2014) 54:130–7. doi:10.1016/j.exger.2014.01.008 
96. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, 
et al. CD57 defines a functionally distinct population of mature NK cells in 
the human CD56dimCD16+ NK-cell subset. Blood (2010) 116(19):3865–74. 
doi:10.1182/blood-2010-04-282301 
97. Fulop T, Le Page A, Garneau H, Azimi N, Baehl S, Dupuis G, et al. Aging, 
immunosenescence and membrane rafts: the lipid connection. Longev 
Healthspan (2012) 1:6. doi:10.1186/2046-2395-1-6 
98. Goronzy JJ, Li G, Yu M, Weyand CM. Signaling pathways in aged T cells – a 
reflection of T cell differentiation, cell senescence and host environment. 
Semin Immunol (2012) 24(5):365–72. doi:10.1016/j.smim.2012.04.003 
99. Chen Y, Gorelik GJ, Strickland FM, Richardson BC. Decreased ERK and 
JNK signaling contribute to gene overexpression in “senescent” CD4+CD28- 
T cells through epigenetic mechanisms. J Leukoc Biol (2010) 87(1):137–45. 
doi:10.1189/jlb.0809562
100. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N, et al. 
Memory T cells and vaccines. Vaccine (2003) 21(5–6):419–30. doi:10.1016/
S0264-410X(02)00407-3 
101. Wahid R, Cannon MJ, Chow M. Virus-specific CD4+ and CD8+ 
cytotoxic T-cell responses and long-term T-cell memory in individuals 
vaccinated against polio. J Virol (2005) 79(10):5988–95. doi:10.1128/
JVI.79.10.5988-5995.2005 
102. Kared H, Camous X, Larbi A. T cells and their cytokines in persistent 
stimulation of the immune system. Curr Opin Immunol (2014) 29:79–85. 
doi:10.1016/j.coi.2014.05.003 
103. Bukczynski J, Wen T, Watts TH. Costimulation of human CD28- T  cells 
by 4-1BB ligand. Eur J Immunol (2003) 33(2):446–54. doi:10.1002/
immu.200310020 
104. Dumitriu IE, Baruah P, Finlayson CJ, Loftus IM, Antunes RF, Lim P, et al. 
High levels of costimulatory receptors OX40 and 4-1BB characterize 
CD4+CD28null T cells in patients with acute coronary syndrome. Circ Res 
(2012) 110(6):857–69. doi:10.1161/CIRCRESAHA.111.261933 
105. Hodge G, Mukaro V, Reynolds PN, Hodge S. Role of increased CD8/
CD28(null) T cells and alternative co-stimulatory molecules in chronic 
obstructive pulmonary disease. Clin Exp Immunol (2011) 166(1):94–102. 
doi:10.1111/j.1365-2249.2011.04455.x 
106. Lee WW, Yang ZZ, Li G, Weyand CM, Goronzy JJ. Unchecked CD70 
expression on T cells lowers threshold for T cell activation in rheu-
matoid arthritis. J Immunol (2007) 179(4):2609–15. doi:10.4049/
jimmunol.179.4.2609 
107. Leitner J, Herndler-Brandstetter D, Zlabinger GJ, Grubeck-Loebenstein 
B, Steinberger P. CD58/CD2 is the primary costimulatory pathway in 
human CD28-CD8+ T cells. J Immunol (2015) 195(2):477–87. doi:10.4049/
jimmunol.1401917 
108. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of 
CD4 T cells in rheumatoid synovitis. Arthritis Rheum (1998) 41(12):2108–16. 
doi:10.1002/1529-0131(199812)41:12<2108::AID-ART5>3.3.CO;2-H 
109. Wagner UG, Kurtin PJ, Wahner A, Brackertz M, Berry DJ, Goronzy JJ, et al. 
The role of CD8+ CD40L+ T cells in the formation of germinal centers in 
rheumatoid synovitis. J Immunol (1998) 161(11):6390–7. 
110. de Magalhaes JP, Church GM. Genomes optimize reproduction: aging as 
a consequence of the developmental program. Physiology (2005) 20:252–9. 
doi:10.1152/physiol.00010.2005 
111. McElwee JJ, Schuster E, Blanc E, Piper MD, Thomas JH, Patel DS, et  al. 
Evolutionary conservation of regulated longevity assurance mechanisms. 
Genome Biol (2007) 8(7):R132. doi:10.1186/gb-2007-8-7-r132 
112. Zwaan BJ. Linking development and aging. Sci Aging Knowledge Environ 
(2003) 2003(47):e32. doi:10.1126/sageke.2003.47.pe32 
113. Kuningas M, Mooijaart SP, van Heemst D, Zwaan BJ, Slagboom PE, 
Westendorp RG. Genes encoding longevity: from model organisms to humans. 
Aging Cell (2008) 7(2):270–80. doi:10.1111/j.1474-9726.2008.00366.x 
114. Sanders AE, Wang C, Katz M, Derby CA, Barzilai N, Ozelius L, et  al. 
Association of a functional polymorphism in the cholesteryl ester transfer 
protein (CETP) gene with memory decline and incidence of dementia. JAMA 
(2010) 303(2):150–8. doi:10.1001/jama.2009.1988 
115. Barzilai N, Atzmon G, Derby CA, Bauman JM, Lipton RB. A genotype of 
exceptional longevity is associated with preservation of cognitive func-
tion. Neurology (2006) 67(12):2170–5. doi:10.1212/01.wnl.0000249116. 
50854.65 
116. Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, Chen J, et  al. 
Association of common genetic variation in the insulin/IGF1 signaling 
pathway with human longevity. Aging Cell (2009) 8(4):460–72. doi:10.1111/ 
j.1474-9726.2009.00493.x 
117. Hawkes K. Grandmothers and the evolution of human longevity. Am J Hum 
Biol (2003) 15(3):380–400. doi:10.1002/ajhb.10156 
118. Hawkes K. Genomic evidence for the evolution of human postmenopausal 
longevity. Proc Natl Acad Sci U S A (2016) 113(1):17–8. doi:10.1073/
pnas.1522936113 
119. Schwarz F, Springer SA, Altheide TK, Varki NM, Gagneux P, Varki A. 
Human-specific derived alleles of CD33 and other genes protect against post-
reproductive cognitive decline. Proc Natl Acad Sci U S A (2016) 113(1):74–9. 
doi:10.1073/pnas.1517951112 
120. Turner AK, Begon M, Jackson JA, Bradley JE, Paterson S. Genetic diversity 
in cytokines associated with immune variation and resistance to multiple 
11
Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
pathogens in a natural rodent population. PLoS Genet (2011) 7(10):e1002343. 
doi:10.1371/journal.pgen.1002343 
121. Kubinak JL, Ruff JS, Hyzer CW, Slev PR, Potts WK. Experimental viral evolu-
tion to specific host MHC genotypes reveals fitness and virulence trade-offs 
in alternative MHC types. Proc Natl Acad Sci U S A (2012) 109(9):3422–7. 
doi:10.1073/pnas.1112633109 
122. Siddle KJ, Quintana-Murci L. The Red Queen’s long race: human adaptation 
to pathogen pressure. Curr Opin Genet Dev (2014) 29:31–8. doi:10.1016/ 
j.gde.2014.07.004 
123. Vallejo AN. Immune remodeling: lessons from repertoire alterations during 
chronological aging and in immune-mediated disease. Trends Mol Med 
(2007) 13(3):94–102. doi:10.1016/j.molmed.2007.01.005 
124. Haynes BF, Sempowski GD, Wells AF, Hale LP. The human thymus during 
aging. Immunol Res (2000) 22(2–3):253–61. doi:10.1385/IR:22:2-3:253 
125. Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, et  al. 
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. 
Blood (2008) 112(2):287–94. doi:10.1182/blood-2007-12-127878 
126. Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier 
C, et al. Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired 
membrane expression of the chemokine receptor CXCR4. Blood (2010) 
115(18):3708–17. doi:10.1182/blood-2009-02-202796 
127. Chandra S, Kronenberg M. Activation and function of iNKT and MAIT cells. 
Adv Immunol (2015) 127:145–201. doi:10.1016/bs.ai.2015.03.003 
128. Pei B, Vela JL, Zajonc D, Kronenberg M. Interplay between carbohydrate and 
lipid in recognition of glycolipid antigens by natural killer T cells. Ann N Y 
Acad Sci (2012) 1253:68–79. doi:10.1111/j.1749-6632.2011.06435.x 
129. Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas 
E, et al. Human NK cells display major phenotypic and functional changes 
over the life span. Aging Cell (2010) 9(4):527–35. doi:10.1111/j.1474-9726. 
2010.00584.x 
130. Pilbeam K, Basse P, Brossay L, Vujanovic N, Gerstein R, Vallejo AN, et al. The 
ontogeny and fate of NK cells marked by permanent DNA rearrangements. 
J Immunol (2008) 180(3):1432–41. doi:10.4049/jimmunol.180.3.1432 
131. Miskov-Zivanov N, Turner MS, Kane LP, Morel PA, Faeder JR. The duration 
of T cell stimulation is a critical determinant of cell fate and plasticity. Sci 
Signal (2013) 6(300):ra97. doi:10.1126/scisignal.2004217 
132. Slack M, Wang T, Wang R. T cell metabolic reprogramming and plasticity. 
Mol Immunol (2015) 68(2 Pt C):507–12. doi:10.1016/j.molimm.2015.07.036 
133. DuPage M, Bluestone JA. Harnessing the plasticity of CD4(+) T cells to 
treat immune-mediated disease. Nat Rev Immunol (2016) 16(3):149–63. 
doi:10.1038/nri.2015.18 
134. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol (2013) 
75:685–705. doi:10.1146/annurev-physiol-030212-183653 
135. Campisi J, Robert L. Cell senescence: role in aging and age-related diseases. 
Interdiscip Top Gerontol (2014) 39:45–61. doi:10.1159/000358899 
136. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. 
Cell (2007) 130(2):223–33. doi:10.1016/j.cell.2007.07.003 
137. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol (2011) 
192(4):547–56. doi:10.1083/jcb.201009094 
138. Adams PD. Healing and hurting: molecular mechanisms, functions, and 
pathologies of cellular senescence. Mol Cell (2009) 36(1):2–14. doi:10.1016/ 
j.molcel.2009.09.021 
139. Munoz-Espin D, Serrano M. Cellular senescence: from physiology to pathol-
ogy. Nat Rev Mol Cell Biol (2014) 15(7):482–96. doi:10.1038/nrm3823 
140. Triana-Martinez F, Pedraza-Vazquez G, Maciel-Baron LA, Konigsberg M. 
Reflections on the role of senescence during development and aging. Arch 
Biochem Biophys (2016) 598:40–9. doi:10.1016/j.abb.2016.04.004 
141. Munoz-Espin D, Canamero M, Maraver A, Gomez-Lopez G, Contreras J, 
Murillo-Cuesta S, et  al. Programmed cell senescence during mammalian 
embryonic development. Cell (2013) 155(5):1104–18. doi:10.1016/ 
j.cell.2013.10.019 
142. Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo 
V, et  al. Senescence is a developmental mechanism that contributes to 
embryonic growth and patterning. Cell (2013) 155(5):1119–30. doi:10.1016/ 
j.cell.2013.10.041 
143. Barral S, Cosentino S, Costa R, Andersen SL, Christensen K, Eckfeldt JH, et al. 
Exceptional memory performance in the Long Life Family Study. Neurobiol 
Aging (2013) 34(11):2445–8. doi:10.1016/j.neurobiolaging.2013.05.002 
144. Miller LS, Mitchell MB, Woodard JL, Davey A, Martin P, Poon LW, et  al. 
Cognitive performance in centenarians and the oldest old: norms from the 
Georgia Centenarian Study. Neuropsychol Dev Cogn B Aging Neuropsychol 
Cogn (2010) 17(5):575–90. doi:10.1080/13825585.2010.481355 
145. Kaup AR, Nettiksimmons J, Harris TB, Sink KM, Satterfield S, Metti AL, et al. 
Cognitive resilience to apolipoprotein E epsilon4: contributing factors in 
Black and White older adults. JAMA Neurol (2015) 72(3):340–8. doi:10.1001/
jamaneurol.2014.3978 
146. Barral S, Cosentino S, Christensen K, Newman AB, Perls TT, Province MA, 
et al. Common genetic variants on 6q24 associated with exceptional episodic 
memory performance in the elderly. JAMA Neurol (2014) 71(12):1514–9. 
doi:10.1001/jamaneurol.2014.1663 
147. Bonafe M, Olivieri F. Genetic polymorphism in long-lived people: cues 
for the presence of an insulin/IGF-pathway-dependent network affecting 
human longevity. Mol Cell Endocrinol (2009) 299(1):118–23. doi:10.1016/j.
mce.2008.10.038 
148. Carru C, Pes GM, Deiana L, Baggio G, Franceschi C, Lio D, et al. Association 
between the HFE mutations and longevity: a study in Sardinian population. 
Mech Ageing Dev (2003) 124(4):529–32. doi:10.1016/S0047-6374(03) 
00032-0 
149. Cupples LA, Arruda HT, Benjamin EJ, D’Agostino RB Sr, Demissie S, 
DeStefano AL, et al. The Framingham Heart Study 100K SNP genome-wide 
association study resource: overview of 17 phenotype working group reports. 
BMC Med Genet (2007) 8(Suppl 1):S1. doi:10.1186/1471-2350-8-S1-S1 
150. Lotrich FE, Albusaysi S, Ferrell RE. Brain-derived neurotrophic factor serum 
levels and genotype: association with depression during interferon-alpha 
treatment. Neuropsychopharmacology (2013) 38(6):985–95. doi:10.1038/
npp.2012.263 
151. Carlson MC, Erickson KI, Kramer AF, Voss MW, Bolea N, Mielke M, et al. 
Evidence for neurocognitive plasticity in at-risk older adults: the experi-
ence corps program. J Gerontol A Biol Sci Med Sci (2009) 64(12):1275–82. 
doi:10.1093/gerona/glp117 
152. Erickson KI, Gildengers AG, Butters MA. Physical activity and brain plas-
ticity in late adulthood. Dialogues Clin Neurosci (2013) 15(1):99–108. 
153. Frandin K, Gronstedt H, Helbostad JL, Bergland A, Andresen M, Puggaard 
L, et  al. Long-term effects of individually tailored physical training and 
activity on physical function, well-being and cognition in Scandinavian 
nursing home residents: a randomized controlled trial. Gerontology (2016) 
62(6):571–80. doi:10.1159/000443611
154. Rejeski WJ, Axtell R, Fielding R, Katula J, King AC, Manini TM, et  al. 
Promoting physical activity for elders with compromised function: the life-
style interventions and independence for elders (LIFE) study physical activity 
intervention. Clin Interv Aging (2013) 8:1119–31. doi:10.2147/CIA.S49737 
155. Berchicci M, Lucci G, Di Russo F. Benefits of physical exercise on the aging 
brain: the role of the prefrontal cortex. J Gerontol A Biol Sci Med Sci (2013) 
68(11):1337–41. doi:10.1093/gerona/glt094 
156. Burzynska AZ, Wong CN, Voss MW, Cooke GE, Gothe NP, Fanning J, et al. 
Physical activity is linked to greater moment-to-moment variability in 
spontaneous brain activity in older adults. PLoS One (2015) 10(8):e0134819. 
doi:10.1371/journal.pone.0134819 
157. Campos C, Rocha NB, Lattari E, Paes F, Nardi AE, Machado S. Exercise-
induced neuroprotective effects on neurodegenerative diseases: the key role 
of trophic factors. Expert Rev Neurother (2016) 16(6):723–34. doi:10.1080/ 
14737175.2016.1179582 
158. Eggenberger P, Wolf M, Schumann M, de Bruin ED. Exergame and balance 
training modulate prefrontal brain activity during walking and enhance 
executive function in older adults. Front Aging Neurosci (2016) 8:66. 
doi:10.3389/fnagi.2016.00066 
159. Erickson KI, Raji CA, Lopez OL, Becker JT, Rosano C, Newman AB, 
et  al. Physical activity predicts gray matter volume in late adulthood: the 
Cardiovascular Health Study. Neurology (2010) 75(16):1415–22. doi:10.1212/
WNL.0b013e3181f88359 
160. Voss MW, Prakash RS, Erickson KI, Basak C, Chaddock L, Kim JS, et  al. 
Plasticity of brain networks in a randomized intervention trial of exercise 
training in older adults. Front Aging Neurosci (2010) 2:32. doi:10.3389/
fnagi.2010.00032 
161. Venkatraman VK, Aizenstein H, Guralnik J, Newman AB, Glynn NW, 
Taylor  C, et  al. Executive control function, brain activation and white 
12
Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
matter hyperintensities in older adults. Neuroimage (2009) 49(4):3436–42. 
doi:10.1016/j.neuroimage.2009.11.019 
162. Gomez-Pinilla F, Zhuang Y, Feng J, Ying Z, Fan G. Exercise impacts 
brain-derived neurotrophic factor plasticity by engaging mecha-
nisms of epigenetic regulation. Eur J Neurosci (2011) 33(3):383–90. 
doi:10.1111/j.1460-9568.2010.07508.x 
163. Kobilo T, Guerrieri D, Zhang Y, Collica SC, Becker KG, van Praag H. AMPK 
agonist AICAR improves cognition and motor coordination in young and 
aged mice. Learn Mem (2014) 21(2):119–26. doi:10.1101/lm.033332.113 
164. Kohman RA, Rodriguez-Zas SL, Southey BR, Kelley KW, Dantzer R, 
Rhodes  JS. Voluntary wheel running reverses age-induced changes in 
hippocampal gene expression. PLoS One (2011) 6(8):e22654. doi:10.1371/
journal.pone.0022654 
165. Neidl R, Schneider A, Bousiges O, Majchrzak M, Barbelivien A, de Vasconcelos 
AP, et al. Late-life environmental enrichment induces acetylation events and 
nuclear factor kappaB-dependent regulations in the hippocampus of aged rats 
showing improved plasticity and learning. J Neurosci (2016) 36(15):4351–61. 
doi:10.1523/JNEUROSCI.3239-15.2016 
166. Schrager MA, Roth SM, Ferrell RE, Metter EJ, Russek-Cohen E, Lynch NA, 
et  al. Insulin-like growth factor-2 genotype, fat-free mass, and muscle 
performance across the adult life span. J Appl Physiol (2004) 97(6):2176–83. 
doi:10.1152/japplphysiol.00985.2003 
167. Hortobagyi T, Rider P, Gruber AH, DeVita P. Age and muscle strength 
mediate the age-related biomechanical plasticity of gait. Eur J Appl Physiol 
(2016) 116(4):805–14. doi:10.1007/s00421-015-3312-8 
168. Konopka AR, Trappe TA, Jemiolo B, Trappe SW, Harber MP. Myosin heavy 
chain plasticity in aging skeletal muscle with aerobic exercise training. 
J Gerontol A Biol Sci Med Sci (2011) 66(8):835–41. doi:10.1093/gerona/glr088 
169. Reeves ND, Maganaris CN, Narici MV. Plasticity of dynamic muscle per-
formance with strength training in elderly humans. Muscle Nerve (2005) 
31(3):355–64. doi:10.1002/mus.20275 
170. Urso ML, Fiatarone Singh MA, Ding W, Evans WJ, Cosmas AC, Manfredi TG. 
Exercise training effects on skeletal muscle plasticity and IGF-1 receptors in 
frail elders. Age (2005) 27(2):117–25. doi:10.1007/s11357-005-1629-7 
171. Snijders T, Nederveen JP, McKay BR, Joanisse S, Verdijk LB, van Loon LJ, 
et al. Satellite cells in human skeletal muscle plasticity. Front Physiol (2015) 
6:283. doi:10.3389/fphys.2015.00283 
172. Anderson JE. The satellite cell as a companion in skeletal muscle plasticity: 
currency, conveyance, clue, connector and colander. J Exp Biol (2006) 
209(Pt 12):2276–92. doi:10.1242/jeb.02088 
173. Newman AB, Murabito JM. The epidemiology of longevity and exceptional 
survival. Epidemiol Rev (2013) 35:181–97. doi:10.1093/epirev/mxs013 
174. Newman AB, Boudreau RM, Naydeck BL, Fried LF, Harris TB. A physiologic 
index of comorbidity: relationship to mortality and disability. J Gerontol 
A Biol Sci Med Sci (2008) 63(6):603–9. doi:10.1093/gerona/63.6.603 
175. Rosano C, Venkatraman VK, Guralnik J, Newman AB, Glynn NW, Launer L, 
et al. Psychomotor speed and functional brain MRI 2 years after completing a 
physical activity treatment. J Gerontol A Biol Sci Med Sci (2010) 65(6):639–47. 
doi:10.1093/gerona/glq038 
176. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait 
speed and survival in older adults. JAMA (2011) 305(1):50–8. doi:10.1001/
jama.2010.1923 
177. Robertson DA, Savva GM, Coen RF, Kenny RA. Cognitive function in the 
prefrailty and frailty syndrome. J Am Geriatr Soc (2014) 62(11):2118–24. 
doi:10.1111/jgs.13111 
178. Burke GL, Arnold AM, Bild DE, Cushman M, Fried LP, Newman A, et al. 
Factors associated with healthy aging: the cardiovascular health study. J Am 
Geriatr Soc (2001) 49(3):254–62. doi:10.1046/j.1532-5415.2001.4930254.x 
179. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, 
Borhani  NO. Recruitment of adults 65 years and older as participants 
in the Cardiovascular Health Study. Ann Epidemiol (1993) 3(4):358–66. 
doi:10.1016/1047-2797(93)90062-9 
180. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. 
J Clin Psychiatry (1987) 48(8):314–8. 
181. Lawton MP, Brody EM. Assessment of older people: self-maintaining and 
instrumental activities of daily living. Gerontologist (1969) 9(3):179–86. 
doi:10.1093/geront/9.3_Part_1.179 
182. Michel JJ, Turesson C, Lemster B, Atkins SR, Iclozan C, Bongartz T, et al. 
CD56-expressing T cells that have features of senescence are expanded in 
rheumatoid arthritis. Arthritis Rheum (2007) 56(1):43–57. doi:10.1002/
art.22310 
183. Bergstrom I, Backteman K, Lundberg A, Ernerudh J, Jonasson L. Persistent 
accumulation of interferon-gamma-producing CD8+CD56+ T cells in 
blood from patients with coronary artery disease. Atherosclerosis (2012) 
224(2):515–20. doi:10.1016/j.atherosclerosis.2012.07.033 
184. Hamzaoui A, Chaouch N, Grairi H, Ammar J, Hamzaoui K. Inflammatory 
process of CD8+ CD28- T cells in induced sputum from asthmatic patients. 
Mediators Inflamm (2005) 2005(3):160–6. doi:10.1155/MI.2005.160 
185. Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, 
et al. Selective decrease in colonic CD56(+) T and CD161(+) T cells in the 
inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 
(2007) 13(45):5995–6002. doi:10.3748/wjg.13.5995 
186. Yonekura K, Ichida T, Sato K, Yamagiwa S, Uchida M, Sugahara S, et al. Liver-
infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver 
(2000) 20(5):357–65. doi:10.1034/j.1600-0676.2000.020005357.x 
187. El-Gazzar A, Cai X, Reeves RS, Dai Z, Caballero-Benitez A, McDonald DL, 
et  al. Effects on tumor development and metastatic dissemination by the 
NKG2D lymphocyte receptor expressed on cancer cells. Oncogene (2014) 
33(41):4932–40. doi:10.1038/onc.2013.435 
188. Cai X, Dai Z, Reeves RS, Caballero-Benitez A, Duran KL, Delrow JJ, et al. 
Autonomous stimulation of cancer cell plasticity by the human NKG2D 
lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS One 
(2014) 9(10):e108942. doi:10.1371/journal.pone.0108942 
189. Capraru D, Muller A, Csernok E, Gross WL, Holl-Ulrich K, Northfield J, et al. 
Expansion of circulating NKG2D+ effector memory T-cells and expression 
of NKG2D-ligand MIC in granulomaous lesions in Wegener’s granulo-
matosis. Clin Immunol (2008) 127(2):144–50. doi:10.1016/j.clim.2007. 
12.004 
190. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell 
autoreactivity by anomalous expression of NKG2D and its MIC ligands 
in rheumatoid arthritis. Proc Natl Acad Sci U S A (2003) 100(16):9452–7. 
doi:10.1073/pnas.1632807100 
191. Hanaoka N, Jabri B, Dai Z, Ciszewski C, Stevens AM, Yee C, et al. NKG2D 
initiates caspase-mediated CD3zeta degradation and lymphocyte receptor 
impairments associated with human cancer and autoimmune disease. 
J Immunol (2010) 185(10):5732–42. doi:10.4049/jimmunol.1002092 
192. Tang F, Chen Z, Ciszewski C, Setty M, Solus J, Tretiakova M, et al. Cytosolic 
PLA2 is required for CTL-mediated immunopathology of celiac disease 
via NKG2D and IL-15. J Exp Med (2009) 206(3):707–19. doi:10.1084/
jem.20071887 
193. Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and 
emerging therapeutic strategies. Nat Rev Rheumatol (2016) 12(1):49–62. 
doi:10.1038/nrrheum.2015.169 
194. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ. 
Modulation of CD28 expression with anti-tumor necrosis factor alpha 
therapy in rheumatoid arthritis. Arthritis Rheum (2005) 52(10):2996–3003. 
doi:10.1002/art.21353 
195. Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, et al. Cell-based 
immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. 
J Immunol (2005) 174(11):7292–301. doi:10.4049/jimmunol.174.11.7292 
196. Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, Stevens AM, et  al. 
Normally occurring NKG2D+CD4+ T cells are immunosuppressive and 
inversely correlated with disease activity in juvenile-onset lupus. J Exp Med 
(2009) 206(4):793–805. doi:10.1084/jem.20081648 
197. Cohavy O, Targan SR. CD56 marks an effector T cell subset in the human 
intestine. J Immunol (2007) 178(9):5524–32. doi:10.4049/jimmunol.178.9. 
5524 
198. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair 
expression of NKG2D and T-cell activation. Nature (2002) 419(6908):734–8. 
doi:10.1038/nature01112 
199. McAlpine SM, Issekutz TB, Marshall JS. Virus stimulation of human mast 
cells results in the recruitment of CD56(+) T cells by a mechanism depen-
dent on CCR5 ligands. FASEB J (2012) 26(3):1280–9. doi:10.1096/fj.11- 
188979 
200. Rong YH, Wan ZH, Song H, Li YL, Zhu B, Zang H, et al. Tim-3 expression 
on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells 
in patients with chronic hepatitis B. Tissue Antigens (2014) 83(2):76–81. 
doi:10.1111/tan.12278 
13
Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
201. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune 
abnormalities in chronic inflammation and persistent infection. Trends Mol 
Med (2004) 10(3):119–24. doi:10.1016/j.molmed.2004.01.002 
202. Hughes KA, Reynolds RM. Evolutionary and mechanistic theories 
of aging. Annu Rev Entomol (2005) 50:421–45. doi:10.1146/annurev.
ento.50.071803.130409 
203. Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, et al. Dual-
functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires 
NK function and retains TCR-mediated specific cytotoxicity. Blood (2011) 
118(12):3301–10. doi:10.1182/blood-2011-02-336321 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Michel, Griffin and Vallejo. This is an open-access article distrib-
uted under the terms of the Creative Commons Attribution License (CC BY). The 
use, distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
